Issue (Lisdexamfetamine Shortages Vyvanse remains under patent in Australia and generic lisdexamfetamine products will not be available.
shortages as of late 2024. The medications facing shortages include methylphenidate, lisdexamfetamine, guanfacine, and atomoxetine, with
stock. This is sometimes due to pharmacist lisdexamfetamine. The shortage of lisdexamfetamine dimesylate say they are not fully available:.
Lisdexamfetamine Dimesylate Capsules, Current Shortages,, . Lisinopril Tablets, Resolved Shortages,, . Lithium
The shortage is further complicated because Vyvanse contains an active ingredient called lisdexamfetamine. Lisdexamfetamine is made in the
shortage-alerts/shortages-vyvanse-lisdexamfetamine-dimesilate-capsules
But these days, especially with the shortage of prescribers, shortage of medications, etc. Vyvanse site – lisdexamfetamine is not affected by
About the shortages of Vyvanse (lisdexamfetamine dimesilate) capsules About the vigabatrin (Sabril) shortage About the Trulicity
Amneal has lisdexamfetamine capsules on shortage due to an issue with the active ingredient. Hikma has lisdexamfetamine capsules on shortage due to an issue with the active ingredient. Lannett has lisdexamfetamine capsules on shortage due to an issue with the active ingredient. Mallinckrodt does not provide information on drug shortages.
Comments